Ken Griffin VYNE THERAPEUTICS INC Transaction History
Citadel Advisors LLC
- $505 Billion
- Q3 2024
Number of Shares
1,187,413
Previous 1,211,066
1.95%
Holding current value
$0
Previous $0
NaN%
% of portfolio
0.0%
Previous 0.0%